{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:30:41Z","timestamp":1760369441908,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.antiviral.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:03:25Z","timestamp":1533647005000},"page":"122-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)-[(3-hydroxy-2-phosphonomethoxy)propyl]- nucleosides in vitro"],"prefix":"10.1016","volume":"158","author":[{"given":"Yohichi","family":"Kumaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Woolcott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason P.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler Z.","family":"Mclean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale L.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadejda","family":"Valiaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Beadle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-2885","authenticated-orcid":false,"given":"Karl Y.","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.08.004_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib3","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib4","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/jm050473m","article-title":"Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses","volume":"49","author":"Beadle","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.08.004_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/421912","article-title":"Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection","volume":"190","author":"Bidanset","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/522969","article-title":"Emergence of adenovirus type 14 in US military recruits\u2013a new challenge","volume":"196","author":"Binn","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00198590","article-title":"A semi-automated neutral red based chemosensitivity assay for drug screening","volume":"8","author":"Cavanaugh","year":"1990","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.antiviral.2018.08.004_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.10.006","article-title":"The acyclic nucleoside phosphonates from inception to clinical use: historical perspective","volume":"75","author":"De Clercq","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2018.08.004_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.08.004_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2018.08.004_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/653498","article-title":"Outbreak of pneumonia associated with emergent human adenovirus serotype 14\u2013Southeast Alaska, 2008","volume":"202","author":"Esposito","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/426831","article-title":"Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro","volume":"191","author":"Hartline","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib17","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.004_bib18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/AAC.01223-05","article-title":"Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro","volume":"50","author":"Hostetler","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/irv.12118","article-title":"Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China","volume":"7","author":"Huang","year":"2013","journal-title":"Influenza Respir. Viruses"},{"key":"10.1016\/j.antiviral.2018.08.004_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.antiviral.2006.05.020","article-title":"Perspectives on the development of acyclic nucleotide analogs as antiviral drugs","volume":"71","author":"Lee","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/598521","article-title":"A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14","volume":"199","author":"Lewis","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib33","first-page":"1181","article-title":"Acute respiratory disease associated with adenovirus serotype 14\u2013four states, 2006-2007","volume":"56","author":"MMWR","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.antiviral.2018.08.004_bib34","first-page":"6","article-title":"Outbreak of adenovirus 14 respiratory illness\u2013Prince of Wales Island, Alaska, 2008","volume":"59","author":"MMWR","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.antiviral.2018.08.004_bib23","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1128\/AAC.00114-09","article-title":"Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo","volume":"53","author":"Morrey","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib24","doi-asserted-by":"crossref","first-page":"8917","DOI":"10.1093\/nar\/17.22.8917","article-title":"Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein","volume":"17","author":"Mul","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib25","article-title":"First reported cases of human adenovirus serotype 14p1 infection, Ireland, October 2009 to July 2010","volume":"16","author":"O'Flanagan","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2018.08.004_bib26","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1167\/iovs.08-3286","article-title":"The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections","volume":"50","author":"Romanowski","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2018.08.004_bib27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/598520","article-title":"Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007","volume":"199","author":"Tate","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.004_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2006.03.007","article-title":"Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro","volume":"72","author":"Valiaeva","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.antiviral.2009.09.012","article-title":"Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses","volume":"84","author":"Valiaeva","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.004_bib30","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/AAC.01546-08","article-title":"The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons","volume":"53","author":"Wyles","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/AAC.35.2.394","article-title":"Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis","volume":"35","author":"Yokota","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.004_bib32","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JVI.00814-12","article-title":"Genome sequence of the first human adenovirus type 14 isolated in China","volume":"86","author":"Zhang","year":"2012","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:47Z","timestamp":1759062527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"alternative-id":["S0166354218303917"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)-[(3-hydroxy-2-phosphonomethoxy)propyl]- nucleosides in vitro","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}